Abstract: Disclosed herein is a method for treating an osteoarthritis in a subject in need thereof. The method mainly includes administering to the subject an effective amount of isolated mitochondria. According to some embodiments of the present disclosure, the isolated mitochondria are administered to the subject in need in the amount of about 1 mg/kg to about 100 mg/kg.

Abstract: Disclosed herein is a method for treating an osteoarthritis in a subject in need thereof. The method mainly includes administering to the subject an effective amount of isolated mitochondria. According to some embodiments of the present disclosure, the isolated mitochondria are administered to the subject in need in the amount of about 1 mg/kg to about 100 mg/kg.

Abstract: An optical tracking system for a medical equipment includes optical markers, optical sensors and a computing device. The optical markers are disposed on the medical equipment. The optical sensors optically sense the optical markers to respectively generate sensing signals. The computing device is coupled to the optical sensors for receiving the sensing signals, and comprises a surgical situation 3-D model. The computing device is configured to adjust a relative position between a virtual medical equipment object and a virtual surgical target object in the surgical situation 3-D model according to the sensing signals.

Abstract: A wearable image display device for surgery includes a display unit, a wireless receiver and a processing core. The wireless receiver wirelessly receives a medical image or a medical instrument information in real-time. The processing core is coupled to the wireless receiver and the display unit for displaying the medical image or the medical instrument information on the display unit.

Abstract: Alleviating neural injury, such as spinal cord injury, in a subject (e.g., a human subject) in need of the treatment using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.

Abstract: An artificial implant for a trapeziometacarpal joint is provided. The artificial implant has a joint replacement portion and at least two insertion rods. The insertion rods of the artificial implant can help to decrease the wound area during the implantation of the artificial implant in order to accelerate the speed of tendon reattachment after implanting and to enhance the ability of anti-rotation.

Abstract: An auxiliary jig for a trapeziometacarpal joint arthroplasty is disclosed. The jig has a body, two grip portions, and a positioning portion. The positioning portion has a plurality of positioning holes so that pins can be fixed on the first metacarpal bone through the positioning holes. The jig can provide accurate positioning operations for cutting and drilling during a trapeziometacarpal joint arthroplasty.

Abstract: An artificial implant for a carpometacarpal (CMC) joint used for replacing a CMC joint surface of the first metacarpal bone is provided and has: an insert portion having an inserting end for inserting into a bone marrow cavity exposed from an incision of the first metacarpal bone, and a front end; an articular replacement portion connected to the front end of the inserting portion and disposed outside the incision of the first metacarpal bone, and having an articular profile surface to replace the CMC joint surface of the first metacarpal bone; and an attached flange protruded from a peripheral of the articular replacement portion, attached to an outer bone surface of the first metacarpal bone adjacent to the incision, and having at least one suture hole, through which at least one suture passes for assisting to fix an abductor pollicis longus (APL) to the outer bone surface.

Abstract: Alleviating neural injury, such as spinal cord injury, in a subject (e.g., a human subject) in need of the treatment using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.